Welcome to our dedicated page for Selectquote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on Selectquote stock.
SelectQuote, Inc. operates a direct-to-consumer insurance distribution and healthcare services platform that connects consumers with Medicare, life, and auto and home insurance policies from carrier partners. Its model combines licensed agents, consultative needs analysis, proprietary lead sourcing and routing technology, and commission revenue from policy sales.
Recurring company developments include fiscal earnings, segment results for Senior, Healthcare Services, Life, and Auto & Home, Medicare Advantage policy volume, SelectRx membership and pharmacy economics, prescription drug reimbursement changes, and cash flow and capital-structure updates. SelectQuote also reports initiatives such as the SelectQuote Local franchise channel, research on e-broker access to Medicare Advantage, conference participation, and NYSE listing-standard compliance.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
SelectQuote, Inc. (NYSE: SLQT) is set to release its fiscal third quarter 2023 financial results on May 11, 2023, before market opening. CEO Tim Danker and CFO Ryan Clement will conduct a conference call at 8:30 am ET to discuss these results. The call will be accessible via registration, with an invitation sent to participants via email.
Founded in 1985, SelectQuote specializes in providing Medicare insurance policies and operates a Healthcare Services platform. The company's services span several domains, including Medicare, Pharmacy, and Value-Based Care, aiming to enhance health outcomes and reduce healthcare costs. It has established four primary business lines: Senior, Healthcare Services, Life, and Auto and Home.
SelectQuote, Inc. (NYSE: SLQT) has regained compliance with the New York Stock Exchange’s minimum stock price requirement as of February 28, 2023. The company received a notice on March 1, 2023, confirming that its average share price exceeded $1.00, addressing a previous deficiency communicated on October 20, 2022. While there are no immediate plans for a reverse stock split, the company will seek shareholder approval for a proposal that allows the Board to effect a reverse split in the future if deemed necessary. A special meeting for stockholders is scheduled for March 2, 2023.